Concepedia

Thomas N. Kakuda

TN

57

Publications

2.3K

Citations

27

H-Index

2000

Active since

Affiliations

Janssen (Belgium)(Current)

Janssen (United States)

University of Colorado Health

University of Hong Kong

University of Minnesota

Thomas N. Kakuda is an author at Janssen (Belgium) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2000–2024

57

Publications

57

Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection

Man‐Fung Yuen, Edward Gane, Dong Joon Kim et al. · Gastroenterology · 2019 · 149 citations

Concentration-controlled compared with conventional antiretroviral therapy for HIV infection

Courtney V. Fletcher, Peter L. Anderson, Thomas N. Kakuda et al. · AIDS · 2002 · 147 citations

Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy?

Kees Brinkman, Thomas N. Kakuda · Current Opinion in Infectious Diseases · 2000 · 141 citations

, , +19

Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals

Peter L. Anderson, Thomas N. Kakuda, Sagar P. Kawle et al. · AIDS · 2003 · 137 citations

6th International Workshop on Clinical Pharmacology of HIV Therapy

Jennifer J. Kiser, Peter L. Anderson, Thomas N. Kakuda · Expert Opinion on Pharmacotherapy · 2006 · 132 citations

, , +10

Rows per page

1–5 of 57